ArticleScientific reports2026
Distinct long-term effects on lung function and airway remodeling in ovalbumin and house dust mite mouse models of experimental asthma.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lysophosphatidic Acid Receptor 5 (LPAInternational journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although mouse models of acute allergic inflammation (AAI) have long been used to study asthma mechanisms, their ability to reproduce human disease remains controversial and long-term studies of chronic asthma remain scarce. We compared lung function and tissue changes in three experimental asthma models after four months of recovery. Using x-ray-based lung function (XLF) analysis, we assessed lung parameters and diaphragm motion, alongside lung expression of α-smooth muscle actin and key extracellular matrix proteins, collagen and elastin. A severe ovalbumin (OVA) model (SAA) produced stronger acute and long-term effects than a milder OVA model (MAA), reflected in both lung dysfunction and tissue remodeling. Lung function remained impaired in SAA and in a house dust mite (HDM) model months after recovery. However, SAA and HDM showed distinct long-term remodeling: While SAA revealed reduced decay rate, collagen deposition and elastin reduction, HDM induced no histological abnormalities but resulted in smaller lung areas and greater diaphragm motion. This first direct comparison of long-term outcomes across AAI models highlights substantial heterogeneity that parallels differences seen in human asthma. These findings underscore the need for careful model selection in studies of chronic asthma and demonstrate the sensitivity of non-invasive XLF for detecting subtle changes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.